P3 Health Partners (PIII) Competitors $0.20 -0.01 (-4.68%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends PIII vs. FICV, GACQ, PSNL, LFMD, SERA, BDSX, EUDA, QIPT, XGN, and ENZShould you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include Frontier Investment (FICV), Global Consumer Acquisition (GACQ), Personalis (PSNL), LifeMD (LFMD), Sera Prognostics (SERA), Biodesix (BDSX), EUDA Health (EUDA), Quipt Home Medical (QIPT), Exagen (XGN), and Enzo Biochem (ENZ). P3 Health Partners vs. Frontier Investment Global Consumer Acquisition Personalis LifeMD Sera Prognostics Biodesix EUDA Health Quipt Home Medical Exagen Enzo Biochem P3 Health Partners (NASDAQ:PIII) and Frontier Investment (NASDAQ:FICV) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, community ranking, risk, valuation, analyst recommendations, profitability, institutional ownership and media sentiment. Does the media refer more to PIII or FICV? In the previous week, P3 Health Partners had 6 more articles in the media than Frontier Investment. MarketBeat recorded 7 mentions for P3 Health Partners and 1 mentions for Frontier Investment. Frontier Investment's average media sentiment score of 0.00 beat P3 Health Partners' score of -0.49 indicating that Frontier Investment is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment P3 Health Partners 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Frontier Investment 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Does the MarketBeat Community favor PIII or FICV? P3 Health Partners received 4 more outperform votes than Frontier Investment when rated by MarketBeat users. CompanyUnderperformOutperformP3 Health PartnersOutperform Votes426.67% Underperform Votes1173.33% Frontier InvestmentN/AN/A Is PIII or FICV more profitable? Frontier Investment has a net margin of 0.00% compared to P3 Health Partners' net margin of -6.95%. Frontier Investment's return on equity of -41.49% beat P3 Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets P3 Health Partners-6.95% -71.31% -11.93% Frontier Investment N/A -41.49%2.95% Which has higher valuation and earnings, PIII or FICV? Frontier Investment has lower revenue, but higher earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than Frontier Investment, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioP3 Health Partners$1.48B0.05-$57.77M-$0.84-0.24Frontier InvestmentN/AN/A$6.51M$0.3530.60 Which has more risk and volatility, PIII or FICV? P3 Health Partners has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, Frontier Investment has a beta of 0.18, meaning that its share price is 82% less volatile than the S&P 500. Do analysts prefer PIII or FICV? P3 Health Partners currently has a consensus price target of $2.38, suggesting a potential upside of 1,065.36%. Given P3 Health Partners' stronger consensus rating and higher probable upside, equities research analysts plainly believe P3 Health Partners is more favorable than Frontier Investment.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score P3 Health Partners 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Frontier Investment 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals and insiders believe in PIII or FICV? 7.8% of P3 Health Partners shares are held by institutional investors. Comparatively, 37.2% of Frontier Investment shares are held by institutional investors. 17.9% of P3 Health Partners shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryP3 Health Partners and Frontier Investment tied by winning 8 of the 16 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get P3 Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PIII vs. The Competition Export to ExcelMetricP3 Health PartnersHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.90M$617.16M$5.06B$8.82BDividend YieldN/A1.96%5.17%4.07%P/E Ratio-0.2437.32125.9917.81Price / Sales0.053.911,180.3874.38Price / Cash2.4325.4733.8232.53Price / Book0.452.904.684.68Net Income-$57.77M-$10.72M$119.54M$226.08M7 Day Performance-18.45%-2.41%-2.45%-2.04%1 Month Performance-55.11%-2.66%-4.06%0.06%1 Year Performance-82.87%387.76%29.86%24.60% P3 Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PIIIP3 Health Partners3.2506 of 5 stars$0.20-4.7%$2.38+1,065.4%-82.9%$75.44M$1.27B-0.24500Analyst ForecastAnalyst RevisionHigh Trading VolumeFICVFrontier InvestmentN/A$10.71flatN/AN/A$82.79MN/A30.602,021GACQGlobal Consumer AcquisitionN/A$10.21flatN/AN/A$237.69MN/A0.002,021PSNLPersonalis4.1972 of 5 stars$3.46-6.2%$6.81+96.9%+156.3%$260.69M$73.48M0.00400LFMDLifeMD2.3071 of 5 stars$5.42-2.5%$12.00+121.4%-23.7%$240.82M$152.55M0.00230SERASera Prognostics1.0479 of 5 stars$6.03-2.4%N/A+235.0%$208.71M$310,000.000.00120BDSXBiodesix2.6823 of 5 stars$1.19-4.0%$3.06+157.1%-16.2%$173.11M$65.56M-3.05220Negative NewsHigh Trading VolumeEUDAEUDA Health0.1736 of 5 stars$4.38+0.9%N/A+284.2%$106.88M$3.71M0.002QIPTQuipt Home Medical3.2122 of 5 stars$2.42-1.2%$6.25+158.3%-51.2%$105.57M$221.74M0.001,200News CoverageXGNExagen4.7894 of 5 stars$4.20+19.0%$7.00+66.7%+169.2%$62.26M$52.55M0.00220Analyst RevisionGap UpHigh Trading VolumeENZEnzo Biochem0.5149 of 5 stars$0.99-2.0%N/A-22.3%$52.77M$31.91M0.00520 Related Companies and Tools Related Companies FICV Competitors GACQ Competitors PSNL Competitors LFMD Competitors SERA Competitors BDSX Competitors EUDA Competitors QIPT Competitors XGN Competitors ENZ Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PIII) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding P3 Health Partners Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share P3 Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PIII Stock Alerts